Fresenius Medical Care (ETR:FME) Share Price Passes Above 200 Day Moving Average – Should You Sell?

Fresenius Medical Care AG (ETR:FMEGet Free Report)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €41.35 ($44.95) and traded as high as €44.49 ($48.36). Fresenius Medical Care shares last traded at €44.02 ($47.85), with a volume of 859,033 shares trading hands.

Fresenius Medical Care Stock Up 0.5 %

The company has a current ratio of 1.37, a quick ratio of 0.80 and a debt-to-equity ratio of 82.24. The company has a market cap of $13.16 billion, a price-to-earnings ratio of 19.97, a P/E/G ratio of 0.42 and a beta of 0.86. The stock’s 50-day moving average is €45.28 and its 200-day moving average is €41.49.

About Fresenius Medical Care

(Get Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More

Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.